Topic: Pfizer Inc.
Pfizer says Sutent was not working better than Bayer's Nexavar as a treatment for liver cancerPfizer Inc. said Thursday it stopped a late-stage clinical study of its drug Sutent as a treatment for liver cancer. Pfizer said patients who were treated with ...